Submitted by Anonymous (not verified) on 7 October 2026 - 15:45
Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn
Source:
Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn